In a patient with cerebrospinal fluid showing moderate lymphocytic pleocytosis, negative cryptococcal antigen, negative venereal disease research laboratory (VDRL) test, and negative polymerase chain reaction (PCR) for herpes simplex virus (HSV) and other common viruses, should intravenous (IV) acyclovir be continued?

Should IV Acyclovir Be Continued After Negative PCR Results?

Do not stop acyclovir based solely on negative PCR results if the patient has CSF lymphocytic pleocytosis and clinical features consistent with viral encephalitis—repeat the lumbar puncture in 24-48 hours and continue acyclovir until HSV encephalitis is definitively ruled out. 1

Critical Decision Algorithm

The decision to continue or discontinue acyclovir depends on three key factors assessed together:

Continue Acyclovir If:

• CSF shows lymphocytic pleocytosis (your patient has this)
• Altered consciousness persists
• MRI shows abnormalities suggestive of encephalitis
• Initial LP was performed <72 hours after symptom onset

Your patient meets at least one of these criteria (moderate lymphocytic pleocytosis), which mandates continuing treatment 1.

Can Safely Stop Acyclovir Only If ALL of the Following Are Met:

1. Two negative HSV PCRs 24-48 hours apart AND
2. MRI not characteristic for HSV encephalitis (performed >72 hours after symptom onset) AND
3. Normal consciousness AND
4. CSF <5 white cells/mm³

OR

1. Single negative HSV PCR obtained >72 hours after symptom onset AND
2. Unaltered consciousness AND
3. Normal MRI (performed >72 hours after symptom onset) AND
4. CSF <5 cells/mm³ 1

Why False-Negative PCRs Occur

Initial CSF PCR can be falsely negative in 4-25% of proven HSV encephalitis cases 2, 3, 4. This occurs when:

• LP performed <72 hours after symptom onset (most common cause) 1, 2
• LP performed late in illness after viral clearance 1
• Acyclovir already started (though CSF typically remains positive for 7-10 days) 1, 5

Recent data from 273 critically ill patients with PCR-proven HSV encephalitis found that 11 patients (4%) had initial negative PCR, all occurring when LP was performed <4 days after symptom onset 2. Critically, initial negative PCR was independently associated with worse neurologic outcome (adjusted OR 9.89), primarily due to delayed or discontinued acyclovir treatment 2.

The Danger of Premature Discontinuation

Case reports document fatal outcomes when acyclovir was stopped after negative PCR 3, 4, 6. In one autopsy-confirmed case, a patient had two consecutive negative PCRs before a third PCR on day 13 returned positive—by then, irreversible damage had occurred 3. Another patient had negative PCR on days 1 and 9, with positive result only on day 30, ultimately resulting in death 6.

Recommended Management Strategy

For your patient with lymphocytic pleocytosis and negative viral PCRs:

1. Continue IV acyclovir at 10 mg/kg every 8 hours 1

2. Repeat lumbar puncture in 24-48 hours for second HSV PCR 1

3. Obtain or review MRI (if not already done >72 hours after symptom onset) to assess for temporal lobe involvement or other features of HSV encephalitis 1, 2

4. Assess level of consciousness objectively

5. Only discontinue acyclovir if the second PCR is negative AND the patient meets all other stopping criteria listed above 1

Duration of Treatment If HSV Confirmed

If subsequent testing confirms HSV encephalitis, continue IV acyclovir for 14-21 days total, then perform repeat LP to confirm CSF is PCR-negative 1. If still positive, continue IV acyclovir with weekly PCR testing until negative 1.

Common Pitfalls to Avoid

• Never stop acyclovir based on a single negative PCR when CSF pleocytosis is present 1, 2, 3
• Do not be falsely reassured by negative PCR if clinical suspicion remains high 1, 3
• Remember that 23.7% of HSV-1 encephalitis cases may have absent pleocytosis, but your patient has pleocytosis, making HSV more likely 7
• Acyclovir has significant renal toxicity (up to 20% of patients), so maintain adequate hydration and monitor renal function, but this should not prevent appropriate treatment 1, 8

Additional Diagnostic Considerations

While continuing acyclovir, actively pursue alternative diagnoses including:

• Autoimmune encephalitis (anti-NMDAR, other antibodies)
• Other treatable infections (though your patient's cryptococcal antigen and VDRL are negative)
• Consider HSV antibody testing in CSF at 10-14 days if diagnosis remains uncertain 1, 9

The risk of untreated HSV encephalitis (70% mortality without treatment, reduced to 20-30% with acyclovir) far outweighs the risks of continuing empiric therapy 5, 8.